Home     Archives     Search     Authors     About Us     Subscribe     Contact Us  

Search For:
Search In:

The i2P magazine is distributed by email on a monthly basis. Subscription is free and you can unsubscribe at any time.
Subscribe Here
Unsubscribe Here

If you have any concerns for your privacy, please read our Privacy Policy

- Issue 81: April 2009
- Issue 80: March 2009
- Issue 79: February 2009
- Issue 78: December 2008
- Issue 77: November 2008
- Issue 76: October 2008
- Issue 75: September 2008
- Issue 74: August 2008
- Issue 73: July 2008
- Issue 72: June 2008

More Archives
We are in the process of moving all of our articles to the new site.

In the meantime you can find them on the old i2P site.

Australian Self Medication Industry Press Releases

Bob Bowden
Media Contact for the Australian Self Medication Industry

Issue 81: April 2009
Page: 1 of 1 Author's Profile | Send to a Friend | Printer Version

For over 30 years, the Australian Self-Medication Industry has represented companies involved in the manufacture and distribution of non-prescription consumer healthcare products and related firms.
ASMI is the peak industry body for the Australian self-care industry including consumer healthcare products ranging from over-the-counter medicines (OTC) to complementary medicines
Also represented by ASMI are companies providing manufacturers with services, such as advertising, public relations, regulatory consultancy, legal advice and industry statistics.

Topics for this month:

 * ASMI comment on childrenís cough and cold medicines



ASMI comment on children’s cough and cold medicines

The Australian Self-Medication Industry (ASMI), the industry body representing non-prescription consumer healthcare products today reassured parents about the safety of children’s over-the-counter cough and cold medicines.

This follows a recommendation by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) that medicines containing certain ingredients intended to relieve cough and cold symptoms should not be used in children under 6 years of age.

The Executive Director of ASMI, Juliet Seifert, said that parents using these products for children, or who have used them in the past, need not worry.

“The cough and cold medicines in question have been widely used for many years and are safe when used as recommended.

“It is important to note that there is no threat to public health and safety. The change is happening because the clinical data which would be required for new products these days is not available for the children’s cough and cold remedies which have been on the market for decades,” Ms Seifert said.

The TGA is currently undertaking an independent expert review of the issue. ASMI fully supports the examination and is working cooperatively with the TGA.

“In a number of cases, the concerns over these preparations stem from overseas reports where there have been instances of dosing errors and accidental ingestions.

“There is no indication that the adverse events that have occurred elsewhere, and which have been associated with misuse, are evident in Australia.

“Australia’s regulatory system, overseen by the TGA, has facilitated the safe use of cough and cold substances in Australia over many years.

“Children’s cough and cold medicines have been used by parents for decades and millions of doses have been administered. They are seen by many parents and carers as an effective and safe option in treating cough’s and colds,” Ms Seifert said.

Back to Top | Back to Home
Copyright © Computachem Services, All Rights Reserved. Published by Computachem Services, PO Box 297 Alstonville 2477 NSW Australia